Concepedia

Mats Inganäs

MI

Statistics

Publications

31

Citations

2.8K

H-Index

25

Active since

1979

Affiliations

Uppsala University Hospital(Current)

Active Biotech (Sweden)

KTH Royal Institute of Technology

Karolinska University Hospital

Sophiahemmet Hospital

Mats Inganäs is an author at Uppsala University Hospital specializing in oncology, molecular oncology, and cancer genetics.

Publications per year

1979–2010

31

Publications

31

The p53 Gene in Breast Cancer: Prognostic Value of Complementary DNA Sequencing Versus Immunohistochemistry

S. Sjögren, Mats Inganäs, Torbjörn Norberg et al. · JNCI Journal of the National Cancer Institute · 1996 · 388 citations · Full text

, , +16

Prognostic and predictive value of c-erbB-2 overexpression in primary breast cancer, alone and in combination with other prognostic markers.

S. Sjögren, Mats Inganäs, A. Lindgren et al. · Journal of Clinical Oncology · 1998 · 331 citations

, , +17

Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer.

E. Berns, John A. Foekens, R. van Vossen et al. · PubMed · 2000 · 197 citations · Full text

, , +14

Chimeric IgG-binding receptors engineered from staphylococcal protein A and streptococcal protein G.

Margareta Eliasson, Anders Olsson, Elisabeth Palmcrantz et al. · Journal of Biological Chemistry · 1988 · 179 citations · Full text

, , +17

A follow‐up study of children with food allergy. Clinical course in relation to serum IgE‐ and IgG‐antibody levels to milk, egg and fish

A Dannaeus, Mats Inganäs · Clinical & Experimental Allergy · 1981 · 170 citations

, , +17

1–5 of 31